The Risk of Recurrent Anaphylaxis
Objectives To determine the recurrence rate of anaphylaxis in children medically attended in an emergency department (ED), we performed a prospective cohort study to evaluate prehospital and ED management of children with recurrent anaphylaxis and to assess factors associated with recurrent anaphyla...
Gespeichert in:
Veröffentlicht in: | The Journal of pediatrics 2017-01, Vol.180, p.217-221 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 221 |
---|---|
container_issue | |
container_start_page | 217 |
container_title | The Journal of pediatrics |
container_volume | 180 |
creator | O'Keefe, Andrew, MD Clarke, Ann, MD, MSc St. Pierre, Yvan, MSc Mill, Jennifer, BA Asai, Yuka, MD, MSc Eisman, Harley, MD La Vieille, Sebastien, MD Alizadehfar, Reza, MD Joseph, Lawrence, PhD Morris, Judy, MD Gravel, Jocelyn, MD Ben-Shoshan, Moshe, MD, MSc |
description | Objectives To determine the recurrence rate of anaphylaxis in children medically attended in an emergency department (ED), we performed a prospective cohort study to evaluate prehospital and ED management of children with recurrent anaphylaxis and to assess factors associated with recurrent anaphylaxis. Study design As part of the Cross-Canada Anaphylaxis Registry, parents of children with anaphylaxis identified prospectively in 3 EDs and through an emergency medical response service were contacted annually after presentation and queried on subsequent reactions. Cox regression analysis determined factors associated with recurrence. Results Among 292 children who were registered as having had medical attended anaphylaxis, 68.5% completed annual follow-up questionnaires. Forty-seven patients experienced 65 episodes of anaphylaxis during 369 patient-years of follow-up. Food was the trigger in 84.6% of cases, and epinephrine was used in 66.2%. In 50.8%, epinephrine was used outside the health care facility, and 81.7% were brought to a health care facility for treatment. Asthma, reaction triggered by food, and use of epinephrine during the index episode increased the odds of recurrent reaction. Patients whose initial reaction was triggered by peanut were less likely to have a recurrent reaction. Conclusions We report a yearly anaphylaxis recurrence rate of 17.6% in children. There is substantial underuse of epinephrine in cases of anaphylaxis. Educational programs that promote effective avoidance strategies and prompt use of epinephrine are required. |
doi_str_mv | 10.1016/j.jpeds.2016.09.028 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1835430760</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022347616309386</els_id><sourcerecordid>1835430760</sourcerecordid><originalsourceid>FETCH-LOGICAL-c414t-90e68269b87f8c52b989e30db0d5bfac0a544a98d3031085ad822853751311073</originalsourceid><addsrcrecordid>eNqFkc1Lw0AQxRdRbK3-BYLUm5fE2d187B4USvELBKHW87LZTOimaVJ3E7H_vamtHrx4Ggbem8f8HiHnFEIKNLkuw3KNuQ9Zv4QgQ2DigAwpyDRIBOeHZAjAWMCjNBmQE-9LAJARwDEZsDSNeCzZkFzOFzieWb8cN8V4hqZzDut2PKn1erGp9Kf1p-So0JXHs_0ckbf7u_n0MXh-eXiaTp4DE9GoDSRgIlgiM5EWwsQsk0IihzyDPM4KbUDHUaSlyDlwCiLWuWBMxDyNKacUUj4iV7u7a9e8d-hbtbLeYFXpGpvOKyp4HHFIE-ilfCc1rvHeYaHWzq602ygKastGleqbjdqyUSBVz6Z3XewDumyF-a_nB0YvuNkJsH_zw6JT3lisDebWoWlV3th_Am7_-E1la2t0tcQN-rLpXN0TVFR5pkC9buvZtkMTDpKLhH8B_ZqHvA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1835430760</pqid></control><display><type>article</type><title>The Risk of Recurrent Anaphylaxis</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>O'Keefe, Andrew, MD ; Clarke, Ann, MD, MSc ; St. Pierre, Yvan, MSc ; Mill, Jennifer, BA ; Asai, Yuka, MD, MSc ; Eisman, Harley, MD ; La Vieille, Sebastien, MD ; Alizadehfar, Reza, MD ; Joseph, Lawrence, PhD ; Morris, Judy, MD ; Gravel, Jocelyn, MD ; Ben-Shoshan, Moshe, MD, MSc</creator><creatorcontrib>O'Keefe, Andrew, MD ; Clarke, Ann, MD, MSc ; St. Pierre, Yvan, MSc ; Mill, Jennifer, BA ; Asai, Yuka, MD, MSc ; Eisman, Harley, MD ; La Vieille, Sebastien, MD ; Alizadehfar, Reza, MD ; Joseph, Lawrence, PhD ; Morris, Judy, MD ; Gravel, Jocelyn, MD ; Ben-Shoshan, Moshe, MD, MSc</creatorcontrib><description>Objectives To determine the recurrence rate of anaphylaxis in children medically attended in an emergency department (ED), we performed a prospective cohort study to evaluate prehospital and ED management of children with recurrent anaphylaxis and to assess factors associated with recurrent anaphylaxis. Study design As part of the Cross-Canada Anaphylaxis Registry, parents of children with anaphylaxis identified prospectively in 3 EDs and through an emergency medical response service were contacted annually after presentation and queried on subsequent reactions. Cox regression analysis determined factors associated with recurrence. Results Among 292 children who were registered as having had medical attended anaphylaxis, 68.5% completed annual follow-up questionnaires. Forty-seven patients experienced 65 episodes of anaphylaxis during 369 patient-years of follow-up. Food was the trigger in 84.6% of cases, and epinephrine was used in 66.2%. In 50.8%, epinephrine was used outside the health care facility, and 81.7% were brought to a health care facility for treatment. Asthma, reaction triggered by food, and use of epinephrine during the index episode increased the odds of recurrent reaction. Patients whose initial reaction was triggered by peanut were less likely to have a recurrent reaction. Conclusions We report a yearly anaphylaxis recurrence rate of 17.6% in children. There is substantial underuse of epinephrine in cases of anaphylaxis. Educational programs that promote effective avoidance strategies and prompt use of epinephrine are required.</description><identifier>ISSN: 0022-3476</identifier><identifier>EISSN: 1097-6833</identifier><identifier>DOI: 10.1016/j.jpeds.2016.09.028</identifier><identifier>PMID: 27743592</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>anaphylaxis ; Anaphylaxis - drug therapy ; Anaphylaxis - epidemiology ; Child ; Emergency Service, Hospital ; Emergency Treatment ; epinephrine ; Epinephrine - therapeutic use ; Female ; food allergy ; Humans ; Male ; Pediatrics ; Prospective Studies ; Recurrence ; risk ; Risk Assessment</subject><ispartof>The Journal of pediatrics, 2017-01, Vol.180, p.217-221</ispartof><rights>Elsevier Inc.</rights><rights>2016 Elsevier Inc.</rights><rights>Copyright © 2016 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c414t-90e68269b87f8c52b989e30db0d5bfac0a544a98d3031085ad822853751311073</citedby><cites>FETCH-LOGICAL-c414t-90e68269b87f8c52b989e30db0d5bfac0a544a98d3031085ad822853751311073</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0022347616309386$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27743592$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>O'Keefe, Andrew, MD</creatorcontrib><creatorcontrib>Clarke, Ann, MD, MSc</creatorcontrib><creatorcontrib>St. Pierre, Yvan, MSc</creatorcontrib><creatorcontrib>Mill, Jennifer, BA</creatorcontrib><creatorcontrib>Asai, Yuka, MD, MSc</creatorcontrib><creatorcontrib>Eisman, Harley, MD</creatorcontrib><creatorcontrib>La Vieille, Sebastien, MD</creatorcontrib><creatorcontrib>Alizadehfar, Reza, MD</creatorcontrib><creatorcontrib>Joseph, Lawrence, PhD</creatorcontrib><creatorcontrib>Morris, Judy, MD</creatorcontrib><creatorcontrib>Gravel, Jocelyn, MD</creatorcontrib><creatorcontrib>Ben-Shoshan, Moshe, MD, MSc</creatorcontrib><title>The Risk of Recurrent Anaphylaxis</title><title>The Journal of pediatrics</title><addtitle>J Pediatr</addtitle><description>Objectives To determine the recurrence rate of anaphylaxis in children medically attended in an emergency department (ED), we performed a prospective cohort study to evaluate prehospital and ED management of children with recurrent anaphylaxis and to assess factors associated with recurrent anaphylaxis. Study design As part of the Cross-Canada Anaphylaxis Registry, parents of children with anaphylaxis identified prospectively in 3 EDs and through an emergency medical response service were contacted annually after presentation and queried on subsequent reactions. Cox regression analysis determined factors associated with recurrence. Results Among 292 children who were registered as having had medical attended anaphylaxis, 68.5% completed annual follow-up questionnaires. Forty-seven patients experienced 65 episodes of anaphylaxis during 369 patient-years of follow-up. Food was the trigger in 84.6% of cases, and epinephrine was used in 66.2%. In 50.8%, epinephrine was used outside the health care facility, and 81.7% were brought to a health care facility for treatment. Asthma, reaction triggered by food, and use of epinephrine during the index episode increased the odds of recurrent reaction. Patients whose initial reaction was triggered by peanut were less likely to have a recurrent reaction. Conclusions We report a yearly anaphylaxis recurrence rate of 17.6% in children. There is substantial underuse of epinephrine in cases of anaphylaxis. Educational programs that promote effective avoidance strategies and prompt use of epinephrine are required.</description><subject>anaphylaxis</subject><subject>Anaphylaxis - drug therapy</subject><subject>Anaphylaxis - epidemiology</subject><subject>Child</subject><subject>Emergency Service, Hospital</subject><subject>Emergency Treatment</subject><subject>epinephrine</subject><subject>Epinephrine - therapeutic use</subject><subject>Female</subject><subject>food allergy</subject><subject>Humans</subject><subject>Male</subject><subject>Pediatrics</subject><subject>Prospective Studies</subject><subject>Recurrence</subject><subject>risk</subject><subject>Risk Assessment</subject><issn>0022-3476</issn><issn>1097-6833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1Lw0AQxRdRbK3-BYLUm5fE2d187B4USvELBKHW87LZTOimaVJ3E7H_vamtHrx4Ggbem8f8HiHnFEIKNLkuw3KNuQ9Zv4QgQ2DigAwpyDRIBOeHZAjAWMCjNBmQE-9LAJARwDEZsDSNeCzZkFzOFzieWb8cN8V4hqZzDut2PKn1erGp9Kf1p-So0JXHs_0ckbf7u_n0MXh-eXiaTp4DE9GoDSRgIlgiM5EWwsQsk0IihzyDPM4KbUDHUaSlyDlwCiLWuWBMxDyNKacUUj4iV7u7a9e8d-hbtbLeYFXpGpvOKyp4HHFIE-ilfCc1rvHeYaHWzq602ygKastGleqbjdqyUSBVz6Z3XewDumyF-a_nB0YvuNkJsH_zw6JT3lisDebWoWlV3th_Am7_-E1la2t0tcQN-rLpXN0TVFR5pkC9buvZtkMTDpKLhH8B_ZqHvA</recordid><startdate>20170101</startdate><enddate>20170101</enddate><creator>O'Keefe, Andrew, MD</creator><creator>Clarke, Ann, MD, MSc</creator><creator>St. Pierre, Yvan, MSc</creator><creator>Mill, Jennifer, BA</creator><creator>Asai, Yuka, MD, MSc</creator><creator>Eisman, Harley, MD</creator><creator>La Vieille, Sebastien, MD</creator><creator>Alizadehfar, Reza, MD</creator><creator>Joseph, Lawrence, PhD</creator><creator>Morris, Judy, MD</creator><creator>Gravel, Jocelyn, MD</creator><creator>Ben-Shoshan, Moshe, MD, MSc</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170101</creationdate><title>The Risk of Recurrent Anaphylaxis</title><author>O'Keefe, Andrew, MD ; Clarke, Ann, MD, MSc ; St. Pierre, Yvan, MSc ; Mill, Jennifer, BA ; Asai, Yuka, MD, MSc ; Eisman, Harley, MD ; La Vieille, Sebastien, MD ; Alizadehfar, Reza, MD ; Joseph, Lawrence, PhD ; Morris, Judy, MD ; Gravel, Jocelyn, MD ; Ben-Shoshan, Moshe, MD, MSc</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c414t-90e68269b87f8c52b989e30db0d5bfac0a544a98d3031085ad822853751311073</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>anaphylaxis</topic><topic>Anaphylaxis - drug therapy</topic><topic>Anaphylaxis - epidemiology</topic><topic>Child</topic><topic>Emergency Service, Hospital</topic><topic>Emergency Treatment</topic><topic>epinephrine</topic><topic>Epinephrine - therapeutic use</topic><topic>Female</topic><topic>food allergy</topic><topic>Humans</topic><topic>Male</topic><topic>Pediatrics</topic><topic>Prospective Studies</topic><topic>Recurrence</topic><topic>risk</topic><topic>Risk Assessment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>O'Keefe, Andrew, MD</creatorcontrib><creatorcontrib>Clarke, Ann, MD, MSc</creatorcontrib><creatorcontrib>St. Pierre, Yvan, MSc</creatorcontrib><creatorcontrib>Mill, Jennifer, BA</creatorcontrib><creatorcontrib>Asai, Yuka, MD, MSc</creatorcontrib><creatorcontrib>Eisman, Harley, MD</creatorcontrib><creatorcontrib>La Vieille, Sebastien, MD</creatorcontrib><creatorcontrib>Alizadehfar, Reza, MD</creatorcontrib><creatorcontrib>Joseph, Lawrence, PhD</creatorcontrib><creatorcontrib>Morris, Judy, MD</creatorcontrib><creatorcontrib>Gravel, Jocelyn, MD</creatorcontrib><creatorcontrib>Ben-Shoshan, Moshe, MD, MSc</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of pediatrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>O'Keefe, Andrew, MD</au><au>Clarke, Ann, MD, MSc</au><au>St. Pierre, Yvan, MSc</au><au>Mill, Jennifer, BA</au><au>Asai, Yuka, MD, MSc</au><au>Eisman, Harley, MD</au><au>La Vieille, Sebastien, MD</au><au>Alizadehfar, Reza, MD</au><au>Joseph, Lawrence, PhD</au><au>Morris, Judy, MD</au><au>Gravel, Jocelyn, MD</au><au>Ben-Shoshan, Moshe, MD, MSc</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Risk of Recurrent Anaphylaxis</atitle><jtitle>The Journal of pediatrics</jtitle><addtitle>J Pediatr</addtitle><date>2017-01-01</date><risdate>2017</risdate><volume>180</volume><spage>217</spage><epage>221</epage><pages>217-221</pages><issn>0022-3476</issn><eissn>1097-6833</eissn><abstract>Objectives To determine the recurrence rate of anaphylaxis in children medically attended in an emergency department (ED), we performed a prospective cohort study to evaluate prehospital and ED management of children with recurrent anaphylaxis and to assess factors associated with recurrent anaphylaxis. Study design As part of the Cross-Canada Anaphylaxis Registry, parents of children with anaphylaxis identified prospectively in 3 EDs and through an emergency medical response service were contacted annually after presentation and queried on subsequent reactions. Cox regression analysis determined factors associated with recurrence. Results Among 292 children who were registered as having had medical attended anaphylaxis, 68.5% completed annual follow-up questionnaires. Forty-seven patients experienced 65 episodes of anaphylaxis during 369 patient-years of follow-up. Food was the trigger in 84.6% of cases, and epinephrine was used in 66.2%. In 50.8%, epinephrine was used outside the health care facility, and 81.7% were brought to a health care facility for treatment. Asthma, reaction triggered by food, and use of epinephrine during the index episode increased the odds of recurrent reaction. Patients whose initial reaction was triggered by peanut were less likely to have a recurrent reaction. Conclusions We report a yearly anaphylaxis recurrence rate of 17.6% in children. There is substantial underuse of epinephrine in cases of anaphylaxis. Educational programs that promote effective avoidance strategies and prompt use of epinephrine are required.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>27743592</pmid><doi>10.1016/j.jpeds.2016.09.028</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-3476 |
ispartof | The Journal of pediatrics, 2017-01, Vol.180, p.217-221 |
issn | 0022-3476 1097-6833 |
language | eng |
recordid | cdi_proquest_miscellaneous_1835430760 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | anaphylaxis Anaphylaxis - drug therapy Anaphylaxis - epidemiology Child Emergency Service, Hospital Emergency Treatment epinephrine Epinephrine - therapeutic use Female food allergy Humans Male Pediatrics Prospective Studies Recurrence risk Risk Assessment |
title | The Risk of Recurrent Anaphylaxis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T08%3A37%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Risk%20of%20Recurrent%20Anaphylaxis&rft.jtitle=The%20Journal%20of%20pediatrics&rft.au=O'Keefe,%20Andrew,%20MD&rft.date=2017-01-01&rft.volume=180&rft.spage=217&rft.epage=221&rft.pages=217-221&rft.issn=0022-3476&rft.eissn=1097-6833&rft_id=info:doi/10.1016/j.jpeds.2016.09.028&rft_dat=%3Cproquest_cross%3E1835430760%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1835430760&rft_id=info:pmid/27743592&rft_els_id=S0022347616309386&rfr_iscdi=true |